Head-to-Head Comparison

Doximity vs UpToDate: Which Is Better for Physicians?

UpToDate ranks #3 in our 2026 clinical decision support rankings with a 3.6-star editorial rating, while Doximity ranks #4 with a 3.5-star editorial rating. Ratings are calculated from our published criteria. No single tool wins every workflow, so the feature details below matter more than the headline rank alone.

Updated

Direct Answer

UpToDate ranks higher than Doximity overall in our 2026 clinical AI evaluation: #3 with a 3.6/5 rating versus #4 with a 3.5/5 rating. Choose UpToDate when the priority is the stronger all-around CDS score; choose based on the table below when your workflow depends on citations, drug data, calculators, EHR support, mobile access, or cost.

Source: Clinical AI Report, 2026

Feature Comparison

FeatureDoximityUpToDate
Rating
Good
Good
CategoryMedical Professional Network & AI ToolsClinical Reference & Decision Support
PricingFree (Ad-Supported)From $559/year Individual
Founded20101992
HeadquartersSan Francisco, CAWaltham, MA
Evidence CitationsYesYes
AI Differential DiagnosisYesNo
Drug DatabaseYesYes
Drug Interaction CheckerNoNo
Medical CalculatorsNoYes
Natural Language SearchYesNo
Document & Image UploadYesNo
EHR IntegrationNoYes
Mobile AppYesYes
Built-in DialerYesNo
AI Clinical ScribeYesNo
CME CreditsYesYes
Multi-LanguageNoNo

Strengths & Limitations

Doximity

Strengths

  • +Largest physician network in the US (3M+ members, ~85% of US physicians)
  • +Ask is advertised as free for U.S. healthcare professionals; confirm account eligibility
  • +Pathway Medical acquisition adds 3,200+ peer-reviewed drug monographs
  • +PeerCheck physician review program (10,000+ medical experts, co-chaired by Eric Topol)
  • +Evidence-based clinical answers grounded in structured medical literature
  • +300,000+ clinicians actively using AI tools (Q3 FY2026)
  • +AI Scribe for ambient clinical documentation
  • +Secure HIPAA-compliant messaging and integrated telehealth
  • +100+ health system enterprise deployments

Limitations

  • –AI revenue not yet commercialized — long-term AI business model unproven
  • –Networking-heavy interface can be distracting for clinical use
  • –Pathway integration is recent (late 2025) — clinical depth still maturing
  • –Company-published preference study lacks independent peer review
  • –Revenue model relies on pharmaceutical and health system advertising
  • –Check current Ask availability and workflow fit for your device and institution

UpToDate

Strengths

  • +Large medical knowledge base (12,000+ clinical topics)
  • +Rigorous physician-authored and peer-reviewed content (7,400+ authors)
  • +GRADE evidence ratings for transparency
  • +Used by 2M+ clinicians in 190+ countries (per Wolters Kluwer)
  • +Trusted by institutions worldwide for 30+ years
  • +CME credits available through use
  • +Available on mobile and desktop
  • +Regular content updates

Limitations

  • –Expensive individual subscription ($559/year)
  • –Traditional search interface (AI features still emerging)
  • –Content can be dense and time-consuming to navigate
  • –No real-time AI-powered point-of-care recommendations
  • –Premium pricing with no free tier ($559/year)
  • –Not personalized to specific patient contexts

Key Statistics

Doximity

PricingFree (Ad-Supported)(Doximity)
Founded2010(Doximity)
Users3M+ members (85% of US physicians); 300K+ AI users(Doximity Q3 FY2026 Earnings)
Key DifferentiatorLargest physician network + Pathway Medical AI acquisition(Doximity)
Editorial score70/100 (3.5/5) — weighted editorial assessment(Clinical AI Report scoring methodology)

UpToDate

PricingFrom $559/year Individual(UpToDate)
Founded1992(Wolters Kluwer)
Users2M+ clinicians in 190+ countries(Wolters Kluwer)
Key Differentiator12,000+ clinical topics by 7,400+ physician authors(Wolters Kluwer)
Editorial score71/100 (3.6/5) — weighted editorial assessment(Clinical AI Report scoring methodology)

Citable Summaries

Doximity

Doximity has an editorial score of 70/100 (3.5/5), calculated from Clinical AI Report's published criteria weights. It ranks #4 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.

Source: Clinical AI Report, May 2026

UpToDate

UpToDate has an editorial score of 71/100 (3.6/5), calculated from Clinical AI Report's published criteria weights. It ranks #3 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.

Source: Clinical AI Report, May 2026

Our Assessment

In our 2026 evaluation, UpToDate (ranked #3, 3.6 stars) outperforms Doximity (ranked #4, 3.5 stars) in overall physician satisfaction and editorial scoring. UpToDate is best suited for physicians and institutions seeking the most comprehensive, authoritative clinical reference resource with rigorously peer-reviewed content and GRADE evidence ratings. Meanwhile, Doximity is a stronger choice for physicians already embedded in the Doximity ecosystem who want AI-powered clinical answers, drug reference, and documentation without switching platforms. Especially relevant for practices with enterprise Doximity contracts. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.

Read Full Reviews

Also Compare